01 20Gilead Sciences Canada Inc.
01 12261619
02 12298059
03 12416757
04 42470365
05 42566922
06 22678907
07 22720856
08 12845553
09 42847871
01 7ELVITEGRAVIR | COBICISTAT | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
02 6Elvitegravir
03 7Elvitegravir | Cobicistat | Emtricitabine | Tenofovir disoproxil fumarate
01 7TABLET
02 13Tablet
01 12017-07-25
02 12018-07-23
03 12021-07-20
04 42023-11-20
05 42025-05-19
06 42026-12-29
07 22028-02-22
08 22029-05-01
09 12032-08-15
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Brand Name : VITEKTA
Patent Number : 2566922
Filing Date : 2005-05-19
Strength per Unit : 85 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Brand Name : VITEKTA
Patent Number : 2470365
Filing Date : 2003-11-20
Strength per Unit : 85 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Brand Name : VITEKTA
Patent Number : 2470365
Filing Date : 2003-11-20
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Brand Name : VITEKTA
Patent Number : 2566922
Filing Date : 2005-05-19
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2847871
Filing Date : 2006-12-29
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2261619
Filing Date : 1997-07-25
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2566922
Filing Date : 2005-05-19
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2298059
Filing Date : 1998-07-23
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2470365
Filing Date : 2003-11-20
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir disoproxil fumarate
Brand Name : STRIBILD
Patent Number : 2678907
Filing Date : 2008-02-22
Strength per Unit : 150 mg / 150 mg / 200 mg / 300 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
